Christopher Cabanski

Director, Biostatistics at Parker Institute for Cancer Immunotherapy - San Francisco, CA, US

Christopher Cabanski's Colleagues at Parker Institute for Cancer Immunotherapy
Ann Luk

Associate Director, Digital Marketing and Marketing Strategy

Contact Ann Luk

Carisa White

Senior Director, Human Resources

Contact Carisa White

Jennifer Clark

Office Manager and Executive Assistant

Contact Jennifer Clark

Wendy Du

Human Resources Generalist

Contact Wendy Du

View All Christopher Cabanski's Colleagues
Christopher Cabanski's Contact Details
HQ
625-899-7600
Location
Company
Parker Institute for Cancer Immunotherapy
Christopher Cabanski's Company Details
Parker Institute for Cancer Immunotherapy logo, Parker Institute for Cancer Immunotherapy contact details

Parker Institute for Cancer Immunotherapy

San Francisco, CA, US • 100 - 249 Employees
Market Research

For decades, entrenched infrastructure barriers have slowed progress in the fight against cancer and the development of potent immunotherapies. The Parker Institute for Cancer Immunotherapy breaks down these barriers. The result is groundbreaking new research and an intellectual property model that builds collaboration between researchers, nonprofits and industry all working together to get treatments to patients faster.

N/A
Details about Parker Institute for Cancer Immunotherapy
Frequently Asked Questions about Christopher Cabanski
Christopher Cabanski currently works for Parker Institute for Cancer Immunotherapy.
Christopher Cabanski's role at Parker Institute for Cancer Immunotherapy is Director, Biostatistics.
Christopher Cabanski's email address is ***@parkerici.org. To view Christopher Cabanski's full email address, please signup to ConnectPlex.
Christopher Cabanski works in the Research industry.
Christopher Cabanski's colleagues at Parker Institute for Cancer Immunotherapy are Ann Luk, Carisa White, Jennifer Clark, Wendy Du, Monika Lukic, Tim Howes, Robert Schiemann and others.
Christopher Cabanski's phone number is 625-899-7600
See more information about Christopher Cabanski